Health Care & Life Sciences » Pharmaceuticals | Stada Arzneimittel AG

Stada Arzneimittel AG | Balance Sheet

Fiscal year is January-December. All values EUR Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
136
194
170
362
244
346
Total Accounts Receivable
637
555
522
512
551
550
Inventories
524
499
502
485
499
515
Other Current Assets
56
73
60
129
30
35
Total Current Assets
1,353
1,320
1,254
1,488
1,324
1,446
Net Property, Plant & Equipment
318
305
322
323
333
351
Total Investments and Advances
29
23
23
20
44
27
Long-Term Note Receivable
16
2
2
4
1
-
Intangible Assets
1,642
1,632
1,649
1,582
1,474
1,707
Other Assets
4
3
4
3
1
1
Total Assets
3,422
3,346
3,302
3,467
3,222
3,592
ST Debt & Current Portion LT Debt
297
450
276
136
1,313
Accounts Payable
330
339
327
336
336
Income Tax Payable
31
34
39
61
80
Other Current Liabilities
387
363
344
367
311
Total Current Liabilities
1,045
1,185
986
900
2,041
Long-Term Debt
1,145
1,045
1,085
1,338
3
Provision for Risks & Charges
51
30
29
36
35
Deferred Taxes
100
117
126
96
89
Other Liabilities
12
5
8
3
3
Total Liabilities
2,412
2,442
2,283
2,419
2,215
Common Equity (Total)
955
836
946
969
962
Total Shareholders' Equity
955
836
946
969
962
Total Equity
1,010
903
1,019
1,047
1,006
Liabilities & Shareholders' Equity
3,422
3,346
3,302
3,467
3,222
Accumulated Minority Interest
55
67
72
78
44

About Stada Arzneimittel

View Profile
Address
Stadastrasse 2-18
Bad Vilbel Hessen 61118
Germany
Employees -
Website http://www.stada.de
Updated 07/08/2019
STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the Generics and Branded Products segments. The Generics segment produces and distributes generic drugs.